Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fascia Iliaca Block for Hip Arthroscopy
NCT02623361Phase 4
Key facts
- Status
- Completed
- Start
- Feb 2015
- Primary completion
- Jan 2017
- Countries
- 1
- Sponsor
- University of California, San Francisco
- Modality
- Orthosteric Ligands
- Drugs
- ropivacaine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Numeric Pain Score at 1 hour. Started Feb 2015; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Fascia Iliaca Block
Preoperative fascia iliaca block with ropivacaine.
Sham Block
Preoperative sham block with saline.
03
Who it enrols
Adult patients (ASA I-III) scheduled for arthroscopic hip surgery. Excludes patients with chronic pain, contraindications to regional nerve block, or inability to consent.
04
Endpoints
Primary
Numeric Pain Score
Secondary
Leg Strength at Discharge
Patient Satisfaction
Beyond the preview
Go deeper on NCT02623361.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623361.